Search Results
What are the pros and cons of HBsAg loss as the endpoint for treatment? | Jordan Feld, MD, MPH
HBsAg Loss: A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research... | Fabien Zoulim
Will HBsAg depletion restore HBV specific immunity? | Adam Gehring, PhD
Novel Antiviral and Immune Targets to Cure HBV - Fabien Zoulim
HBV cure: what is coming in 5 – 10 years? | Patrick Kennedy, MD
What’s new in Hepatitis B treatment & diagnostics | Seng Gee Lim, MBBS, FRACP, FRCP, MD
Clinical update on reducing HBV virus and antigen production using RNAi | Bruce Given
HBV Cure Initiatives: Science in Action, An Expert Review of Current Data
New Data From Combination Trials for Chronic Hepatitis B - Pietro Lampertico, MD, PhD
HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH
What is the cure rate with current therapies? | Harry Janssen, MD, PhD